News about Matrix Laboratories Limited
November 13th, 2007
The media had reports that Mylan may come out with a delisting offer for Matrix and are looking at buying the residual stake.
The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.
Matrix Laboratories Limited has vide its letter inter-alia stated,”As on date Mylan Laboratories Inc.,USA is neither contemplating to buy residual stake nor delist the securities of the Company from the Stock Exchanges. Hence, the news item is incorrect and baseless.”
Entry Filed under: Equity Markets, NSE
Leave a Comment
Some HTML allowed:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>